Neuvotion is a medical device company focused on creating neurostimulation products aimed at the rehabilitation and physical therapy sectors. The company develops healthcare technology that seeks to restore movement and independence for individuals with movement impairments, such as those resulting from strokes or injuries. By integrating targeted neurostimulation with artificial intelligence, Neuvotion's products provide therapeutic benefits that empower users to manage their own therapy. Additionally, these technologies enable clinicians to utilize advanced tools for monitoring patient progress, either in-person or remotely, enhancing the overall effectiveness of rehabilitation efforts.
Brightline is a technology-enabled behavioral health home for children and their families. Brightline delivers integrated care through innovative technology, virtual behavioral health services, and a collaborative care team focused on supporting children across developmental stages and their families.
Transcarent is a consumer digital health company, uses a combination of software, technology, and data science to empower consumers with information and access, leading to better outcomes and more cost-effective decisions. We believe that having the right information, tools, and incentives in the decision-making process can be positively transformative in the way we all experience healthcare.
Nova Leah Ltd develops SelectEvidence, a cybersecurity risk analysis and treatment solution for medical device manufacturers. It offers 24/7 technical support, online platform training, and continuous software update services. The company was founded in 2015 and is based in Dundalk, Ireland with an additional office in Boston, Massachusetts.
Holmusk Pte. Ltd. is a digital health and data analytics company focused on delivering real-world evidence for mental health and chronic diseases. Founded in 2015 and headquartered in Singapore, with additional offices in New York, Durham, London, and Cyberjaya, Holmusk develops an analytics platform that integrates scientific research, electronic health records, and behavioral health data to provide predictive algorithms and actionable insights for personalized medicine. The company offers solutions such as MindLinc, an electronic health record system that enhances longitudinal data for advanced analytics, and digital therapeutics that monitor and treat patients. Holmusk's platform supports various stakeholders in the healthcare ecosystem, including pharmaceutical companies, healthcare providers, payers, and regulators, facilitating informed care decisions and improving treatment outcomes for individuals managing behavioral health conditions. Through its innovative approach, Holmusk aims to advance data-driven, evidence-based care and aid in the research and development of new therapies.
Clarapath, Inc. specializes in imaging and analysis services for digital pathology, focusing on the automation of tissue processing. The company offers Section Star, an automated device that employs a tape transfer method for microtomy, enhancing the precision and efficiency of tissue sectioning. Clarapath provides a range of services, including routine histology, pathology consultation, whole slide imaging, quantitative image analysis, and long-term data management. Its anatomic pathology laboratory serves both human and animal digital pathology needs, catering to academic researchers, clinical laboratories, and physicians. The company operates from a next-generation laboratory at the NY Genome Center, facilitating large-scale imaging and analysis to support both specialized research projects and broader clinical applications. Founded in 2011 and headquartered in New York, Clarapath aims to transform anatomic pathology through its innovative approach, enabling faster and more accurate results while reducing variability and cross-contamination in tissue processing.
Cognixion, Inc. is a computer software company that focuses on developing innovative solutions for individuals with communication disabilities. Its flagship product, Speakprose, employs a brain-computer interface (BCI) to translate brainwave signals into verbal communication, thus enabling non-verbal individuals to express themselves through artificial intelligence technology. In addition to this, Cognixion also creates a speech-generating device and an eye-tracking system tailored for disabled users. Founded in 2014, the company operates from its headquarters in Santa Barbara, California, and has an additional office in Toronto, Canada. Originally incorporated as Smartstones, Inc., it rebranded to Cognixion in December 2017, reflecting its commitment to advancing communication technology through biosignal recognition.
Developer of a health data platform designed to aggregate data across multiple healthcare systems to provide medical insights. The company's platform de-identifies and aggregates healthcare data, with a focus first on COVID-19, enabling researchers to find cures faster, empower every clinician to be an expert, and help families make the most informed decisions about their care
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.
Peerbridge Health Inc. is a digital health company based in New York that specializes in remote monitoring of vital signs through its innovative wireless electrocardiogram (ECG) technology. The company has developed Peerbridge Cor, a multi-channel ECG monitor that provides physicians with real-time heart data and captures critical insights over a continuous seven-day period to aid in arrhythmia detection. In addition to Peerbridge Cor, the company offers Peerbridge CorHRV and Peerbridge Cor+, which monitor various vital signs including heart rate, respiratory rate, temperature, oxygen saturation, and heart rate variability (HRV). Peerbridge Health holds two patents related to medical-grade monitoring of vital signs, with additional patents pending, reflecting its commitment to enhancing healthcare delivery and patient outcomes through advanced technology. Founded in 2012, the company aims to improve the independence and precision of remote health monitoring for both medical and wellness applications.
Gauss Surgical, Inc. is a medical technology company that specializes in real-time blood monitoring solutions aimed at enhancing patient outcomes during surgical procedures. Founded in 2011 and headquartered in Los Altos, California, Gauss has developed a vision-based platform that accurately measures surgical blood loss using advanced algorithms and artificial intelligence. Its flagship product, Triton, includes various models tailored for different medical settings, such as Triton OR for operating rooms and Triton L&D for labor and delivery. These devices assist healthcare professionals in early recognition of hemorrhage, provide objective metrics for blood loss, and inform transfusion decisions, ultimately improving patient safety and care quality. Gauss Surgical primarily serves the healthcare sector in the United States.
Playback Health, Inc. specializes in creating patient engagement technology aimed at enhancing communication between healthcare practitioners and patients. Based in Mount Kisco, New York, the company's platform allows healthcare providers to design, develop, and share personalized multimedia content, including screen-capture videos, audio messages, and digital documents. This technology is intended to inform and educate patients about their specific diagnoses, treatment options, and discharge procedures. By providing a comprehensive view of the patient's healthcare journey, Playback Health enables patients to share their medical information with family, friends, and care professionals, fostering a collaborative care environment. The platform also integrates with existing healthcare systems to improve the delivery of medical information and instructions, thereby enhancing patient experience and engagement.
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.
Vestagen Technical Textiles is a company based in Orlando, Florida, that develops, manufactures, and markets high-performance textile products for the healthcare sector and beyond. Founded in 2009, it offers a range of items including lab coats and uniforms specifically designed for specialty healthcare workers and patients. The company holds exclusive North American rights to patented Swiss technologies that enable the adaptation of its textiles for various applications, including medical uniforms and athletic apparel. Vestagen sells its products directly to consumers and through retail partners, distributors, and online platforms, ensuring broad accessibility to its innovative textile solutions.
Salaso is a developer of a software as a service platform that enables physiotherapists and other healthcare professionals to prescribe and deliver high-quality exercise videos to patients via smartphones, tablets, or personal computers. The platform includes an e-learning tool designed to engage patients with the content and promote adherence to prescribed home exercise programs. By facilitating the delivery of physiotherapy exercises, Salaso aims to support the recovery process for patients recovering from injuries, ensuring that healthcare providers can effectively manage and monitor their patients' rehabilitation efforts.
Conversa Health, Inc. specializes in developing patient relationship management solutions that enhance communication between patients and healthcare providers. Its primary offering, the Conversa Virtual Care and Communication Platform, enables efficient engagement and improved health outcomes by automating personalized messaging tailored to individual patient profiles, which are derived from electronic health records, biometric devices, and self-reported data. The platform supports various healthcare scenarios, including chronic care management, acute discharge, and preventative wellness. Additionally, Conversa provides Digital Checkups that generate tailored clinical questions and reminders based on patient data. The company serves a diverse clientele, including health systems, pharmaceutical companies, payers, and health technology firms. Founded in 2013 and headquartered in Portland, Oregon, Conversa has expanded its presence with offices in New York, North Carolina, and California. Its solutions are utilized by notable organizations to manage patient engagement, especially during the COVID-19 pandemic, by facilitating symptom checks, lab result communications, and patient monitoring.
Peerbridge Health Inc. is a digital health company based in New York that specializes in remote monitoring of vital signs through its innovative wireless electrocardiogram (ECG) technology. The company has developed Peerbridge Cor, a multi-channel ECG monitor that provides physicians with real-time heart data and captures critical insights over a continuous seven-day period to aid in arrhythmia detection. In addition to Peerbridge Cor, the company offers Peerbridge CorHRV and Peerbridge Cor+, which monitor various vital signs including heart rate, respiratory rate, temperature, oxygen saturation, and heart rate variability (HRV). Peerbridge Health holds two patents related to medical-grade monitoring of vital signs, with additional patents pending, reflecting its commitment to enhancing healthcare delivery and patient outcomes through advanced technology. Founded in 2012, the company aims to improve the independence and precision of remote health monitoring for both medical and wellness applications.
HealthReveal offers a cloud-based clinical analytics platform aimed at preventing the avoidable consequences of chronic diseases. The company employs advanced analytics and biomonitoring technology to continuously monitor and analyze patient health through the integration of various real-time clinical, operational, and biometric data streams. This approach ensures that both clinicians and patients adhere to evidence-based care guidelines, facilitating the early detection and treatment of chronic conditions. By focusing on remote monitoring and data analytics, HealthReveal assists payers and providers in ensuring that patients receive appropriate treatments, ultimately promoting faster recovery and reducing healthcare costs.
Clarapath, Inc. specializes in imaging and analysis services for digital pathology, focusing on the automation of tissue processing. The company offers Section Star, an automated device that employs a tape transfer method for microtomy, enhancing the precision and efficiency of tissue sectioning. Clarapath provides a range of services, including routine histology, pathology consultation, whole slide imaging, quantitative image analysis, and long-term data management. Its anatomic pathology laboratory serves both human and animal digital pathology needs, catering to academic researchers, clinical laboratories, and physicians. The company operates from a next-generation laboratory at the NY Genome Center, facilitating large-scale imaging and analysis to support both specialized research projects and broader clinical applications. Founded in 2011 and headquartered in New York, Clarapath aims to transform anatomic pathology through its innovative approach, enabling faster and more accurate results while reducing variability and cross-contamination in tissue processing.
Avizia is a provider of telehealth and remote conferencing platform to deploy and power system-wide telehealth programs. It is delivering on the vision of collaborative care for patients by connecting medical experts across distance through innovative, leading-edge telemedicine solutions. Supported by Cisco technology, Avizia delivers telemedicine that is as powerful as it is easy to use. Its end-to-end solution includes telemedicine devices, workflow management software, store-and-forward capabilities with EHR integration, and a line of peripherals, such as digital stethoscopes and examination cameras. Whether medical professionals are performing remote medical consultations or teaching a new procedure, Avizia makes the experience feel as if everyone is present. Avizia uses Cisco TelePresence technology to enable HD, real-time video collaboration in hospitals amongst patients and professionals.
PurpleSun is an early stage healthcare technology company based out of New York City. They are focused on providing smart, light-based technology solutions to the healthcare industry for infection prevention, diagnostics and treatment. Their company’s novel light technology platform will be utilized throughout the continuum of care, within hospitals, long term care and surgical centers. The smart devices will set the stage for patient safety through the highest of quality in medical equipment disinfection. Their goal is to prevent healthcare acquired infections, which will ultimately save lives, reduce costs and enhance safety for patients and caregivers. Their clinical data proves best in class efficacy and performance of our platform, and positions PurpleSun to illuminate the healthcare arena.